Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses.

Endotoxin, a lipopolysaccharide (LPS), is a bacterial cell wall product instrumental in producing deleterious host responses to infection. This LPS appears to act, in part, by triggering release of endogenous mediators such as cytokines. Repeated exposures to endotoxin produce attenuated responses to this molecule. To examine the mechanisms and biologic consequences of this tolerance to LPS, Wistar rats were subjected to a 14-day course of LPS administration. Tolerance to LPS with regard to anorexia, weight loss, and acute-phase responses was noted. Attenuation of these physiologic responses was accompanied by abrogation of circulating cytokine appearance in response to endotoxin, suggesting that tolerance to LPS is in part due to a decreased production of cytokines. Tolerance to LPS also diminished the response to a subsequent infected thermal injury, as measured by food intake, body weight, fibrinogen levels, and mortality. Thus, clinical conditions involving repeated exposure to LPS may modify the host's responses to subsequent injury. The attenuated responses to injury accompanying the decreased production of cytokines further implicate cytokines in the pathogenesis of injury and disease.

[1]  E. Deitch The management of burns. , 1990, The New England journal of medicine.

[2]  M. Feldmann,et al.  Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Minei,et al.  Pathophysiologic glucocorticoid elevations promote bacterial translocation after thermal injury , 1990, Infection and immunity.

[4]  R. Berg,et al.  Food without fiber promotes bacterial translocation from the gut. , 1990, Surgery.

[5]  L. Moldawer,et al.  The biologic characteristics of cytokines and their implication in surgical injury. , 1990, Surgery, gynecology & obstetrics.

[6]  N. Christou,et al.  Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. , 1989, Archives of surgery.

[7]  J. Norton,et al.  Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. , 1989, Surgery.

[8]  L. Moldawer,et al.  Anticachectin/tumor necrosis factor‐α antibodies attenuate development of cachexia in tumor models , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  K. Tracey,et al.  Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. , 1989, The American journal of physiology.

[10]  J. Hunt,et al.  Morbidity and mortality of an endemic pathogen: methicillin-resistant Staphylococcus aureus. , 1988, American journal of surgery.

[11]  L. Moldawer,et al.  Cachectin/TNF production in experimental burns and Pseudomonas infection. , 1988, Archives of surgery.

[12]  J. Alverdy,et al.  Total parenteral nutrition promotes bacterial translocation from the gut. , 1988, Surgery.

[13]  J. Norton,et al.  Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity , 1988, The Journal of experimental medicine.

[14]  L. Moldawer,et al.  Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. , 1988, The American journal of physiology.

[15]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[16]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[17]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[18]  W. Fiers,et al.  Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines. , 1986, European journal of cancer & clinical oncology.

[19]  L. Frank Endotoxin-tolerant rats are still protected from oxygen toxicity by low-dose endotoxin treatment. , 1985, Journal of applied physiology.

[20]  V. Farewell,et al.  Using and Understanding Medical Statistics , 1984 .

[21]  S. E. Greisman,et al.  MECHANISMS OF ENDOTOXIN TOLERANCE , 1965, The Journal of experimental medicine.

[22]  S. E. Greisman,et al.  Mechanisms of endotoxin tolerance. I. Relationship between tolerance and reticuloendothelial system phagocytic activity in the rabbit. , 1963 .

[23]  A. Braude,et al.  Studies with radioactive endotoxin. III. The effect of tolerance on the distribution of radioactivity after intravenous injection of Escherichia coli endotoxin labeled with Cr51. , 1958, The Journal of clinical investigation.

[24]  D. Morrison,et al.  Endotoxins and disease mechanisms. , 1987, Annual review of medicine.

[25]  P. Lansdorp,et al.  Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.